These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8935143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia.
    Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, Murakami N, Niho Y.
    Arch Intern Med; 1993 Feb 22; 153(4):509-14. PubMed ID: 7679571
    [Abstract] [Full Text] [Related]

  • 3. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M, Burns LJ, Barker JN, Miller JS, Defor TE, Olujohungbe AB, Weisdorf DJ.
    Biol Blood Marrow Transplant; 2004 Jun 22; 10(6):395-404. PubMed ID: 15148493
    [Abstract] [Full Text] [Related]

  • 4. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S, Shi YK, Liu P, Han XH, He XH, Cai YM, Chen ZM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun 22; 28(3):339-44. PubMed ID: 16900629
    [Abstract] [Full Text] [Related]

  • 5. Treatment of chemotherapy-induced or idiopathic bone marrow aplasia with granulocyte colony-stimulating factor (G-CSF).
    Robak T, Krykowski E, Warzocha K.
    Arch Immunol Ther Exp (Warsz); 1994 Jun 22; 42(5-6):433-8. PubMed ID: 8572903
    [Abstract] [Full Text] [Related]

  • 6. Naturally occurring and therapy-induced antibodies to human granulocyte colony-stimulating factor (G-CSF) in human serum.
    Laricchia-Robbio L, Moscato S, Genua A, Liberati AM, Revoltella RP.
    J Cell Physiol; 1997 Nov 22; 173(2):219-26. PubMed ID: 9365526
    [Abstract] [Full Text] [Related]

  • 7. Collection of peripheral blood progenitor cells for autografting with low-dose cyclophosphamide plus granulocyte colony-stimulating factor.
    Bellido M, Sureda A, Martino R, Madoz P, García J, Brunet S.
    Haematologica; 1998 May 22; 83(5):428-31. PubMed ID: 9658727
    [Abstract] [Full Text] [Related]

  • 8. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G, Yeh HS.
    J Clin Psychiatry; 1994 Sep 22; 55(9):401-5. PubMed ID: 7523362
    [Abstract] [Full Text] [Related]

  • 9. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF, Chan HO.
    Pharmacotherapy; 2005 Mar 22; 25(3):372-8. PubMed ID: 15843284
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human granulocyte and granulocyte-macrophage colony-stimulating factor (G-CSF and GM-CSF) administered following cytotoxic chemotherapy have a similar ability to mobilize peripheral blood stem cells.
    Hohaus S, Martin H, Wassmann B, Egerer G, Haus U, Färber L, Burger KJ, Goldschmidt H, Hoelzer D, Haas R.
    Bone Marrow Transplant; 1998 Oct 22; 22(7):625-30. PubMed ID: 9818688
    [Abstract] [Full Text] [Related]

  • 11. Treatment of drug-induced agranulocytosis with colony stimulating factors (G-CSF or GM-CSF).
    Góra-Tybor J, Krykowski E, Robak T.
    Arch Immunol Ther Exp (Warsz); 1996 Oct 22; 44(4):255-8. PubMed ID: 9017166
    [Abstract] [Full Text] [Related]

  • 12. Prospective randomized comparative observation of single- vs split-dose lenograstim to mobilize peripheral blood progenitor cells following chemotherapy in patients with multiple myeloma or non-Hodgkin's lymphoma.
    Kim S, Kim HJ, Park JS, Lee J, Chi HS, Park CJ, Huh J, Suh C.
    Ann Hematol; 2005 Oct 22; 84(11):742-7. PubMed ID: 16132903
    [Abstract] [Full Text] [Related]

  • 13. Granulocyte-colony stimulating factor therapy in drug-induced agranulocytosis.
    Mani S, Barry M, Concato J.
    Arch Intern Med; 1993 Nov 08; 153(21):2500-1. PubMed ID: 7692832
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products.
    Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller EK.
    Biol Blood Marrow Transplant; 2004 Dec 08; 10(12):848-57. PubMed ID: 15570253
    [Abstract] [Full Text] [Related]

  • 18. Role of granulocyte colony stimulating factor (G-CSF) in chemotherapy induced neutropenia.
    Ghalaut PS, Sen R, Dixit G.
    J Assoc Physicians India; 2008 Dec 08; 56():942-4. PubMed ID: 19322972
    [Abstract] [Full Text] [Related]

  • 19. Mobilization of peripheral blood progenitor cells with vinorelbine and granulocyte colony-stimulating factor in multiple myeloma patients is reliable and cost effective.
    Bargetzi MJ, Passweg J, Baertschi E, Schoenenberger A, Gwerder C, Tichelli A, Burger J, Mingrone W, Herrmann R, Gratwohl A, Wernli M.
    Bone Marrow Transplant; 2003 Jan 08; 31(2):99-103. PubMed ID: 12621490
    [Abstract] [Full Text] [Related]

  • 20. A phase II study of recombinant human granulocyte-colony stimulating factor (rHuG-CSF, lenograstim) in the treatment of agranulocytosis in children.
    Donadieu J, Boutard P, Tchernia G, Oster G, Gordon-Smith EC, Philippe N, Le Gall E, Nivelon JL, Dopfer P, Babin-Boilletot A.
    Nouv Rev Fr Hematol (1978); 1994 Dec 08; 36(6):441-8. PubMed ID: 7538658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.